← Back to Search

Patient Nudge for Lung Cancer Screening

N/A
Waitlist Available
Led By Debra Ritzwoller, PhD
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Qualifies for Lung Cancer Screening based on USPSTF criteria (aged 50-80, at least 20 pack years smoking history, currently smoke or quit in the last 15 years)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if sending a reminder message to eligible patients for lung cancer screening, who haven't had a screening before and have an upcoming appointment with their doctor, will improve the screening rates.

Who is the study for?
This trial is for individuals who qualify for lung cancer screening but haven't undergone it yet and have an upcoming doctor's appointment scheduled. Specific inclusion or exclusion criteria are not detailed.
What is being tested?
The study is evaluating the impact of sending electronic reminder messages to patients eligible for lung cancer screening on their engagement with getting screened.
What are the potential side effects?
Since this trial involves sending reminder messages rather than medical interventions, there are no direct side effects associated with the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50-80 years old and have a significant smoking history.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The proportion completed a visit with a Primary Care provider by receipt of an electronic letter or paper letter
The proportion completing a low-dose computed tomography (LDCT) lung cancer screen (LCS) scan by receipt of an electronic letter or paper letter
The proportion receiving an order to get a low-dose computed tomography (LDCT) lung cancer screen (LCS) scan by receipt of an electronic letter or paper letter

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Birth year = even AND not active on KP.orgExperimental Treatment1 Intervention
Has an upcoming primary care visit, qualifies for LCS based on USPSTF criteria, receives a mailed letter informing that they qualify for LCS and reminding to talk to provider about LCS at next visit.
Group II: Birth year = even AND active on KP.orgExperimental Treatment1 Intervention
Has an upcoming primary care visit, qualifies for lung cancer screening based on USPSTF criteria, receives an electronic letter via KP.org informing that they qualify for LCS and reminding to talk to PCP about LCS at next visit.
Group III: Birth year = oddActive Control1 Intervention
No intervention, care as usual

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor
552 Previous Clinical Trials
27,728,968 Total Patients Enrolled
Debra Ritzwoller, PhDPrincipal InvestigatorKaiser Permanente
~2274 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top